Barriers to recruit female commercial sex workers for HIV vaccine trials: The Rio de Janeiro experience

Journal of Acquired Immune Deficiency Syndromes

Volumn 50, Issue 1, 2009, Pages 116-117

  Barroso, Paulo Feijó ^a,b   De Souza, Monica Barbosa ^a   Do Lago, Regina Ferro ^a   Pedrosa, Jorge ^a   Yoshida, Carina Beppu ^a   Faulhaber, José Cláudio ^a   Costa, Marcellus Dias ^a   Schechter, Mauro ^a,b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Infectious Diseases Service   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

BRAZIL; COCAINE DEPENDENCE; HIGH RISK BEHAVIOR; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LETTER; MEDICAL RESEARCH; PATIENT PARTICIPATION; PRIORITY JOURNAL; PROSTITUTION; SEXUALLY TRANSMITTED DISEASE; CLINICAL TRIAL; FEMALE; HUMAN; METHODOLOGY; PATIENT SELECTION; PILOT STUDY; PSYCHOLOGICAL ASPECT; SEXUAL BEHAVIOR;

AIDS VACCINES; BRAZIL; CLINICAL TRIALS AS TOPIC; FEMALE; HIV INFECTIONS; HUMANS; PATIENT SELECTION; PILOT PROJECTS; PROSTITUTION; SEXUAL BEHAVIOR;

EID: 64249097211     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31818d5e3f     Document Type: Letter

References (2)

1. Djomand G, Metch B, Zorrilla C, et al. The HVTN Protocol 903 Vaccine Preparedness Study: lessons learned in preparation For HIV Vaccine Efficacy Trials [published ahead of print, March 27, 2008]. J Acquir Immune Defic Syndr. 2008.
2. Robertson M, Mehrotra D, Fitzgerald D, et al. Efficacy results from the Step Study (Merck V520Protocol 023/HVTN 502): a phase II test of concept trial of the MRKAd5HIV-1 Gag/Pol/Nef trivalent Vaccine [88LB]. Presented at: The 15th Conference on Retrovirus and Opportunistic Infections; February 3-6, 2008; Boston, MA.